ALIBHLINFTECUNSPADR Valuation
| TWYA Stock | EUR 12.10 0.30 2.42% |
At this time, the firm appears to be overvalued. ALIBHLINFTECUNSPADR shows a prevailing Real Value of €9.79 per share. The current price of the firm is €12.1. Our model approximates the value of ALIBHLINFTECUNSPADR from examining the firm fundamentals such as Return On Equity of 0.0088, profit margin of 0.01 %, and Operating Margin of (0.02) % as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ALIBHLINFTECUNSPADR's price fluctuation is slightly risky at this time. Calculation of the real value of ALIBHLINFTECUNSPADR is based on 3 months time horizon. Increasing ALIBHLINFTECUNSPADR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ALIBHLINFTECUNSPADR stock is determined by what a typical buyer is willing to pay for full or partial control of ALIBHLINFTECUNSPADR. Since ALIBHLINFTECUNSPADR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ALIBHLINFTECUNSPADR Stock. However, ALIBHLINFTECUNSPADR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.1 | Real 9.79 | Hype 12.1 | Naive 11.92 |
The real value of ALIBHLINFTECUNSPADR Stock, also known as its intrinsic value, is the underlying worth of ALIBHLINFTECUNSPADR Company, which is reflected in its stock price. It is based on ALIBHLINFTECUNSPADR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ALIBHLINFTECUNSPADR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ALIBHLINFTECUNSPADR helps investors to forecast how ALIBHLINFTECUNSPADR stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ALIBHLINFTECUNSPADR more accurately as focusing exclusively on ALIBHLINFTECUNSPADR's fundamentals will not take into account other important factors: ALIBHLINFTECUNSPADR Total Value Analysis
ALIBHLINFTECUNSPADR is at this time anticipated to have takeover price of 0 with market capitalization of 10.11 B, debt of 37.74 M, and cash on hands of 11.64 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ALIBHLINFTECUNSPADR fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 10.11 B | 37.74 M | 11.64 B |
ALIBHLINFTECUNSPADR Investor Information
The company had not issued any dividends in recent years. Based on the analysis of ALIBHLINFTECUNSPADR's profitability, liquidity, and operating efficiency, ALIBHLINFTECUNSPADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.ALIBHLINFTECUNSPADR Asset Utilization
One of the ways to look at asset utilization of ALIBHLINFTECUNSPADR is to check how much profit was generated for every dollar of assets it reports. ALIBHLINFTECUNSPADR shows a negative utilization of assets of -0.0168 percent, losing €1.68E-4 for each euro of assets held by the firm. Inefficient asset utilization signifies that the company is being less productive with each euro of assets it shows. Put another way, asset utilization of ALIBHLINFTECUNSPADR shows how inadequate it operates for each euro spent on its assets.ALIBHLINFTECUNSPADR Profitability Analysis
The company reported the revenue of 22.72 B. Net Income was 348.59 M with profit before overhead, payroll, taxes, and interest of 4.11 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ALIBHLINFTECUNSPADR's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ALIBHLINFTECUNSPADR and how it compares across the competition.
About ALIBHLINFTECUNSPADR Valuation
The stock valuation mechanism determines ALIBHLINFTECUNSPADR's current worth on a weekly basis. Our valuation model uses a comparative analysis of ALIBHLINFTECUNSPADR. We calculate exposure to ALIBHLINFTECUNSPADR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ALIBHLINFTECUNSPADR's related companies.Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, medical and healthcare services, and digital infrastructure businesses in the Peoples Republic of China. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. ALIB HL operates under Pharmaceutical Retailers classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1033 people.
8 Steps to conduct ALIBHLINFTECUNSPADR's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ALIBHLINFTECUNSPADR's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ALIBHLINFTECUNSPADR's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ALIBHLINFTECUNSPADR's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ALIBHLINFTECUNSPADR's revenue streams: Identify ALIBHLINFTECUNSPADR's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ALIBHLINFTECUNSPADR's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ALIBHLINFTECUNSPADR's growth potential: Evaluate ALIBHLINFTECUNSPADR's management, business model, and growth potential.
- Determine ALIBHLINFTECUNSPADR's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ALIBHLINFTECUNSPADR's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ALIBHLINFTECUNSPADR Stock analysis
When running ALIBHLINFTECUNSPADR's price analysis, check to measure ALIBHLINFTECUNSPADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALIBHLINFTECUNSPADR is operating at the current time. Most of ALIBHLINFTECUNSPADR's value examination focuses on studying past and present price action to predict the probability of ALIBHLINFTECUNSPADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALIBHLINFTECUNSPADR's price. Additionally, you may evaluate how the addition of ALIBHLINFTECUNSPADR to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |